A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
for Lupus Erythematosus, Systemic
15 locations incl. San Francisco
Sponsor: AstraZeneca
Sex: All·Age: 18 - 70
Code: NCT06897930·Phase 1, Phase 2·Recruiting